Global Oxygen Therapy Equipment Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Oxygen Therapy Equipment Market Size

• The global oxygen therapy equipment market size was valued at USD 2.14 billion in 2024 and is expected to reach USD 4.35 billion by 2032, at a CAGR of 9.3% during the forecast period
• The market growth is largely fueled by the increasing prevalence of respiratory conditions such as COPD, asthma, and sleep apnea, which has intensified the demand for advanced oxygen delivery systems across both hospital and homecare settings. The rising geriatric population globally further adds to the high need for continuous oxygen therapy, driving consistent market expansion
• Furthermore, ongoing technological advancements in oxygen concentrators, portable oxygen cylinders, and wearable oxygen therapy solutions are enhancing patient comfort and mobility. These innovations are enabling healthcare providers to offer more efficient and personalized treatment, thus accelerating the uptake of oxygen therapy equipment solutions and significantly boosting the industry's growth

Oxygen Therapy Equipment Market Analysis

• The Oxygen Therapy Equipment market is experiencing significant growth, driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea, as well as rising pollution levels and an aging global population
• The rising demand for home-based oxygen therapy solutions, coupled with technological advancements in portable oxygen concentrators, is reshaping patient care by providing mobility, comfort, and better health outcomes, especially for elderly and chronic patients
• North America dominated the oxygen therapy equipment market, accounting for the largest revenue share of 39.4% in 2024, fueled by a high burden of respiratory diseases, well-established healthcare infrastructure, and a growing preference for home-based treatment options. The U.S., in particular, has witnessed strong growth due to favorable reimbursement policies and the widespread use of advanced oxygen delivery systems
• Asia-Pacific is projected to be the fastest-growing region in the oxygen therapy equipment market during the forecast period, expanding at a CAGR of 9.8% from 2025 to 2032, attributed to increasing urbanization, rising air pollution, expanding healthcare expenditure, and a growing elderly population in countries such as China, India, and Japan
• The oxygen source equipment segment dominated the oxygen therapy equipment market with a revenue share of 61.4% in 2024, owing to the high demand for oxygen concentrators and oxygen cylinders, especially for treating chronic respiratory conditions such as COPD and during post-operative care. These devices are essential in both hospital and home care settings for continuous oxygen support

Report Scope and Oxygen Therapy Equipment Market Segmentation

Oxygen Therapy Equipment Market Trends

Increasing Adoption of Home-Based Oxygen Therapy Solutions

• A significant and accelerating trend in the global Oxygen Therapy Equipment market is the rising adoption of home-based oxygen therapy, driven by the growing prevalence of chronic respiratory conditions such as COPD, sleep apnea, and pulmonary fibrosis
• The COVID-19 pandemic further intensified the need for at-home oxygen support, pushing healthcare providers and patients to shift from hospital-based to portable and home-based solutions for long-term respiratory care
• Leading manufacturers are now focused on developing lightweight, user-friendly portable oxygen concentrators (POCs) that provide mobility and convenience for patients, enabling greater adherence to treatment and improved quality of life
• In addition, increased awareness campaigns by respiratory health organizations and governments are helping to destigmatize oxygen therapy use at home, thereby encouraging early intervention and better disease management
• The development of battery-operated and wearable oxygen therapy devices is gaining traction, especially among elderly populations and patients in rural or remote areas with limited access to continuous hospital care
• As healthcare systems worldwide shift toward value-based care, oxygen therapy equipment is becoming central to strategies aimed at reducing hospital readmission rates and managing chronic respiratory illnesses more cost-effectively

Oxygen Therapy Equipment Market Dynamics

Driver

Growing Need Due to Rising Respiratory Disorders and Home-Based Care Demand

• The increasing prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and sleep apnea is a major driver for the rising demand for oxygen therapy equipment worldwide
• The global burden of respiratory disorders has heightened the need for accessible oxygen support, especially among the aging population and patients with comorbidities such as cardiovascular diseases
• The trend toward home-based healthcare has further propelled the adoption of oxygen concentrators and portable oxygen cylinders, which allow patients to receive continuous respiratory support outside of hospital settings
• Favorable reimbursement policies, especially in developed countries such as the U.S., Germany, and Japan, are supporting the use of oxygen therapy equipment in both chronic care management and post-acute recovery scenarios
• Technological advancements in oxygen delivery systems, such as portable oxygen concentrators with extended battery life, auto-adjust flow rates, and integrated monitoring, are enhancing patient compliance and convenience

Restraint/Challenge

High Initial Costs and Limited Awareness in Low-Income Regions

• The high upfront cost of advanced oxygen therapy equipment such as portable oxygen concentrators remains a significant barrier, particularly in low- and middle-income countries where access to medical infrastructure is limited
• In rural and underserved areas, lack of awareness and education about the benefits of oxygen therapy often results in underdiagnosis and delayed treatment of respiratory illnesses
• Supply chain challenges, including delays in device delivery and shortages of medical-grade oxygen in critical regions, especially during health emergencies, have disrupted access to therapy
• Infrastructure limitations, such as unreliable electricity or insufficient training for device usage and maintenance, hinder widespread adoption in resource-limited settings
• Concerns over long-term affordability for consumables and refills, such as nasal cannulas, masks, and oxygen cylinders, add to the economic burden for patients and caregivers
• To overcome these challenges, stakeholders must focus on cost-effective device innovation, government-supported oxygen delivery programs, and capacity-building initiatives in primary care settings to ensure equitable access to oxygen therapy worldwide

Oxygen Therapy Equipment Market Scope

The market is segmented on the basis of product type, portability, application, and end user.

• By Product Type

On the basis of product type, the oxygen therapy equipment market is segmented into bag-valve mask and oxygen source equipment. The oxygen source equipment segment dominated the largest market revenue share of 61.4% in 2024, owing to the high demand for oxygen concentrators and oxygen cylinders, especially for treating chronic respiratory conditions such as COPD and during post-operative care. These devices are essential in both hospital and home care settings for continuous oxygen support.

The bag-valve mask segment is expected to witness the fastest CAGR of 7.8% from 2025 to 2032, due to its increased usage in emergency settings and pre-hospital care. Its portability and effectiveness in manually providing positive pressure ventilation make it a critical component in ambulances and critical care units.

• By Portability

On the basis of portability, the oxygen therapy equipment market is segmented into portable and stationary. The stationary segment held the largest market revenue share of 54% in 2024, primarily due to its widespread use in hospitals and clinics for patients requiring continuous oxygen therapy. These devices offer higher flow rates and are ideal for long-term treatments.

The portable segment is anticipated to witness the fastest growth rate of 9.2% during the forecast period, driven by rising demand for mobility among elderly and chronically ill patients. With growing preference for home care and active lifestyles, lightweight and travel-friendly oxygen concentrators are gaining popularity across developed and emerging markets.

• By Application

On the basis of application, the oxygen therapy equipment market is segmented into asthma, pneumonia, chronic obstructive pulmonary disease (COPD), respiratory distress syndrome, cystic fibrosis, and others. The chronic obstructive pulmonary disease (COPD) segment dominated the largest market share of 37.6% in 2024, due to the high prevalence of COPD globally, particularly among the aging population and smokers. Oxygen therapy remains a standard treatment for COPD patients with low blood oxygen levels.

The respiratory distress syndrome segment is projected to experience the fastest CAGR of 4.5%, spurred by the rising number of preterm births and neonatal respiratory complications. Advancements in neonatal intensive care units (NICUs) and increasing awareness among pediatricians are supporting the growth of oxygen therapy use in this segment.

• By End User

On the basis of end user, the oxygen therapy equipment market is segmented into hospitals and clinics, ambulatory surgical centers, home care settings, and others. The hospitals and clinics segment accounted for the largest market revenue share of 55% in 2024 due to the increasing number of hospital admissions related to respiratory diseases and surgeries that require oxygen supplementation. These settings are equipped with advanced oxygen delivery systems and trained staff to manage acute cases.

The home care settings segment is expected to grow at the fastest CAGR through 2032, driven by a surge in demand for decentralized and cost-effective treatment options. With an aging population and the shift toward remote patient monitoring, home-based oxygen therapy solutions are becoming more prevalent.

Oxygen Therapy Equipment Market Regional Analysis

• North America dominated the oxygen therapy equipment market with the largest revenue share of 39.4% in 2024, driven by a high burden of chronic respiratory diseases, strong healthcare infrastructure
• Increasing demand for portable and home-based oxygen delivery systems. Widespread use of oxygen concentrators, coupled with favorable reimbursement policies, supports regional dominance
• The region also benefits from early adoption of advanced medical devices, increased awareness of oxygen therapy's role in managing conditions such as COPD, asthma, and sleep apnea, and a well-established network of homecare providers. This has led to strong market penetration across both hospital and non-hospital settings

U.S. Oxygen Therapy Equipment Market Insight

The U.S. oxygen therapy equipment market captured the largest revenue share in 2024 within North America, supported by an aging population, high prevalence of respiratory illnesses, and the country's commitment to advancing home healthcare solutions. Demand is further propelled by the availability of portable oxygen concentrators and liquid oxygen systems designed for long-term use. Continuous innovation in device miniaturization and oxygen flow optimization is helping improve patient mobility and quality of life, especially in outpatient settings.

Europe Oxygen Therapy Equipment Market Insight

The Europe oxygen therapy equipment market is projected to expand at a substantial CAGR throughout the forecast period, owing to increased diagnosis rates of pulmonary diseases, rising healthcare expenditures, and support for at-home care. National health insurance schemes across countries such as Germany, France, and the U.K. have helped promote oxygen therapy adoption by covering a wide range of respiratory care devices and consumables. Moreover, public awareness campaigns and improved patient monitoring technologies are driving early intervention and continuous care for chronic respiratory conditions.

U.K. Oxygen Therapy Equipment Market Insight

The U.K. oxygen therapy equipment market is anticipated to grow at a noteworthy CAGR during the forecast period, fueled by National Health Service (NHS) support for domiciliary oxygen therapy and efforts to reduce hospital readmissions related to respiratory distress. A growing number of elderly patients and individuals with post-COVID respiratory complications are contributing to market growth. The emphasis on enhancing patient compliance and monitoring via telehealth and remote oxygen saturation tracking solutions is creating new opportunities in the market.

Germany Oxygen Therapy Equipment Market Insight

The Germany oxygen therapy equipment market is expected to expand at a considerable CAGR, due to rising awareness of chronic lung conditions and robust investment in pulmonary rehabilitation. Germany’s healthcare system supports both hospital-based and home-based respiratory therapy, making it one of the leading countries in Europe in terms of device adoption. Technological advancements in oxygen delivery systems and the growing preference for compact, noiseless concentrators are helping meet patient-centric needs.

Asia-Pacific Oxygen Therapy Equipment Market Insight

The Asia-Pacific oxygen therapy equipment market is poised to grow at the fastest CAGR of 9.8% during the forecast period of 2025 to 2032, supported by increasing urbanization, air pollution levels, and rising geriatric populations. Countries such as India and China are experiencing a sharp rise in respiratory complications, leading to increased demand for both emergency and long-term oxygen therapy. Government-led initiatives for improving rural healthcare access and investments in public health infrastructure are expected to boost adoption across the region.

Japan Oxygen Therapy Equipment Market Insight

The Japan oxygen therapy equipment market is gaining momentum, driven by the country’s aging population and emphasis on geriatric respiratory care. A strong tradition of medical device innovation and high public health standards position Japan as a key market for portable oxygen concentrators and oxygen conservers. Demand is also rising due to increasing awareness of post-operative and post-infection oxygen needs, especially among elderly patients living independently.

China Oxygen Therapy Equipment Market Insight

The China oxygen therapy equipment market accounted for the largest market revenue share in Asia-Pacific in 2024, thanks to rapid urban development, rising air pollution, and expanding middle-class healthcare demands. China is a major manufacturing hub for oxygen equipment, which contributes to local affordability and availability. Public hospital expansions, along with health insurance schemes that cover oxygen therapy for chronic respiratory diseases, continue to strengthen the market’s growth outlook.

Oxygen Therapy Equipment Market Share

The oxygen therapy equipment industry is primarily led by well-established companies, including:

• Koninklijke Philips N.V. (Netherlands)
• ResMed Inc. (U.S.)
• Invacare Corporation (U.S.)
• Drive DeVilbiss Healthcare (U.S.)
• CAIRE Inc. (U.S.)
• Nidek Medical Products, Inc. (U.S.)
• O2 Concepts, LLC (U.S.)
• Inogen, Inc. (U.S.)
• Fisher & Paykel Healthcare Corporation Limited (New Zealand)
• Messer Group GmbH (Germany)
• Air Liquide (France)
• GCE Group (Sweden)
• Precision Medical, Inc. (U.S.)
• BESCO Medical Limited (China)
• Sanrai International (India)

Latest Developments in Global Oxygen Therapy Equipment Market

• In June 2025, Inogen introduced the Voxi 5 stationary oxygen concentrator, a compact device delivering 1–5 L/min of quiet, continuous oxygen, designed with lockable casters and a 3-year sieve bed warranty. The launch strengthens Inogen’s home-care credentials and broadens its offerings beyond portable units
• In April 2025, the UK’s Defence Science and Technology Laboratory (Dstl), in collaboration with Defence Medical Services, unveiled a 5 kg lightweight portable oxygen system intended for military and emergency use. It enhances casualty response by offering safe, reusable oxygen delivery without the drawbacks of heavy cylinders
• In March–April 2025, Belluscura, a Texas-based portable oxygen device maker, withdrew its financial guidance after highlighting risks associated with U.S. tariffs on Chinese-manufactured components. This move underscores the vulnerability of device makers to supply-chain disruption and trade dynamics in the portable oxygen market

SKU-9772